BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.
Show more Aaron Rosenberg Chief Financial Officer & Principal Financial Officer
Wang Lai Global Head of R&D
Titus Ball Vice President & Chief Accounting Officer
Liza Heapes Head of Investor Relations
Jaspreet Jaggi Senior Vice President & Head of Clinical Portfolio Strategy
Xiaodong Wang Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder
Yan Qi Senior Vice President & Head of Public Affairs - Greater China
Melika Davis Senior Vice President & Global Head, Clinical Operations
John V. Oyler Co-Founder, Executive Chairman & Chief Executive Officer
Xiaobin Wu President & Chief Operating Officer
Chan Lee General Counsel & Senior Vice President
Yang Ji Chief Compliance Officer